BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29134670)

  • 1. Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer.
    Kalsbeek AMF; Chan EKF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM
    Prostate; 2018 Jan; 78(1):25-31. PubMed ID: 29134670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.
    Kalsbeek AM; Chan EF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM
    Aging (Albany NY); 2016 Oct; 8(11):2702-2712. PubMed ID: 27705925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection.
    Maragh S; Veltri RW; Lund SP; Mangold L; Isharwal S; Christudass CS; Partin AW; Humphreys EB; Sorbara L; Srivastava S; Wagner PD
    Cancer Biomark; 2015; 15(6):763-73. PubMed ID: 26406418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood mitochondrial DNA copy number is associated with prostate cancer risk and tumor burden.
    Zhou W; Zhu M; Gui M; Huang L; Long Z; Wang L; Chen H; Yin Y; Jiang X; Dai Y; Tang Y; He L; Zhong K
    PLoS One; 2014; 9(10):e109470. PubMed ID: 25279731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial genome microsatellite instability and copy number alteration in lung carcinomas.
    Dai JG; Zhang ZY; Liu QX; Min JX
    Asian Pac J Cancer Prev; 2013; 14(4):2393-9. PubMed ID: 23725147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
    Koochekpour S; Marlowe T; Singh KK; Attwood K; Chandra D
    PLoS One; 2013; 8(9):e74688. PubMed ID: 24086362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
    Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
    Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ
    BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of mitochondrial DNA copy number and the risk of prostate cancer.
    Moore A; Lan Q; Hofmann JN; Liu CS; Cheng WL; Lin TT; Berndt SI
    Cancer Causes Control; 2017 Jun; 28(6):529-538. PubMed ID: 28357528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
    Pierorazio PM; Lin BM; Mullins JK; Hyndman ME; Schaeffer EM; Han M; Partin AW; Pavlovich CP
    Urol Oncol; 2013 Jul; 31(5):589-94. PubMed ID: 21664838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
    Elliott SP; Shinohara K; Logan SL; Carroll PR
    J Urol; 2002 Jul; 168(1):105-9. PubMed ID: 12050501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells.
    Mizumachi T; Muskhelishvili L; Naito A; Furusawa J; Fan CY; Siegel ER; Kadlubar FF; Kumar U; Higuchi M
    Prostate; 2008 Mar; 68(4):408-17. PubMed ID: 18196528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme.
    Isharwal S; Makarov DV; Carter HB; Epstein JI; Partin AW; Landis P; Marlow C; Veltri RW
    BJU Int; 2010 Feb; 105(3):329-33. PubMed ID: 19678815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients.
    Dang S; Qu Y; Wei J; Shao Y; Yang Q; Ji M; Shi B; Hou P
    Diagn Pathol; 2014 Feb; 9():28. PubMed ID: 24499477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues.
    Wang Y; Liu VW; Xue WC; Tsang PC; Cheung AN; Ngan HY
    Gynecol Oncol; 2005 Jul; 98(1):104-10. PubMed ID: 15921730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
    Srinivasainagendra V; Sandel MW; Singh B; Sundaresan A; Mooga VP; Bajpai P; Tiwari HK; Singh KK
    Genome Med; 2017 Mar; 9(1):31. PubMed ID: 28356157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
    Zhou M; Magi-Galluzzi C
    Pathology; 2010 Jun; 42(4):334-8. PubMed ID: 20438405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis.
    Spratt DE; Zumsteg Z; Ghadjar P; Pangasa M; Pei X; Fine SW; Yamada Y; Kollmeier M; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1254-61. PubMed ID: 23182392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
    Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
    Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.